IFP Advisors Inc acquired a new position in shares of Cibus, Inc. (NASDAQ:CBUS – Free Report) during the fourth quarter, HoldingsChannel reports. The institutional investor acquired 13,000 shares of the company’s stock, valued at approximately $36,000.
A number of other institutional investors have also modified their holdings of the business. HighTower Advisors LLC grew its position in Cibus by 20.6% in the 3rd quarter. HighTower Advisors LLC now owns 16,125 shares of the company’s stock valued at $52,000 after buying an additional 2,750 shares during the last quarter. Charles Schwab Investment Management Inc. grew its position in Cibus by 14.6% in the 3rd quarter. Charles Schwab Investment Management Inc. now owns 49,285 shares of the company’s stock valued at $161,000 after buying an additional 6,276 shares during the last quarter. B. Riley Wealth Advisors Inc. purchased a new position in Cibus in the 3rd quarter valued at $44,000. Virtu Financial LLC purchased a new position in Cibus in the 3rd quarter valued at $48,000. Finally, Barclays PLC grew its position in Cibus by 287.2% in the 3rd quarter. Barclays PLC now owns 20,269 shares of the company’s stock valued at $66,000 after buying an additional 15,034 shares during the last quarter. 33.81% of the stock is owned by institutional investors and hedge funds.
Analysts Set New Price Targets
A number of research firms recently weighed in on CBUS. HC Wainwright reiterated a “buy” rating and issued a $25.00 price objective on shares of Cibus in a research report on Monday, November 11th. Canaccord Genuity Group lowered their price objective on shares of Cibus from $20.00 to $18.00 and set a “buy” rating on the stock in a research report on Wednesday, January 22nd.
Cibus Stock Performance
Shares of NASDAQ CBUS opened at $2.15 on Friday. The firm has a market capitalization of $56.88 million, a P/E ratio of -0.10 and a beta of 2.04. Cibus, Inc. has a one year low of $1.80 and a one year high of $23.18. The company’s fifty day moving average is $2.45 and its two-hundred day moving average is $3.73.
Cibus Profile
Cibus, Inc, a agricultural biotechnology company, develops and licenses plant traits to seed companies for royalties. The company primarily focus on trait productivity in two areas, including productivity traits that enable farmers to have higher yields and reduce the use of the crop protection chemicals and fertilizers; and sustainable ingredients that enable corporations to replace ingredients that are fossil fuel based or whose production results in increased greenhouse gases.
Featured Stories
- Five stocks we like better than Cibus
- Top Biotech Stocks: Exploring Innovation Opportunities
- Investing in Small-Cap AI: Powering the Next Tech Revolution
- Dividend Payout Ratio Calculator
- Occidental Petroleum Drops to 52-Week Low: Buy, Sell, or Hold?
- The Risks of Owning Bonds
- Super Micro Computer Is Now NASDAQ Compliant—But Is It a Buy?
Want to see what other hedge funds are holding CBUS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cibus, Inc. (NASDAQ:CBUS – Free Report).
Receive News & Ratings for Cibus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cibus and related companies with MarketBeat.com's FREE daily email newsletter.